Dr. Fadi T.  Khasawneh

Dr. Fadi T. Khasawneh

Research Scientist
Western University of Health Sciences, USA


Highest Degree
PostDoc. in Platelet Biology from University of Illinois at Chicago, Chicago, IL, USA

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Cardiovascular Pharmacology
62%
Pharmaceutical Sciences
90%
Thrombosis
75%
Platelet Biology
55%

Selected Publications

  1. Ting, H.J. and F.T. Khasawneh, 2010. Platelet function and isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family. J. Biomed. Sci., 17: 24-24.
    CrossRef  |  PubMed  |  Direct Link  |  

  2. Ting, H.J. and F.T. Khasawneh, 2010. Glybenclamide: An antidiabetic with in vivo antithrombotic activity. Eur. J. Pharmacol., 649: 249-254.
    CrossRef  |  PubMed  |  Direct Link  |  

  3. Srinivasan, S., F. Mir, J. Huang, F.T. Khasawneh, S.C. Lam and G.C. Le Breton, 2009. The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), Can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels. J. Biol. Chem., 284: 16108-16117.
    CrossRef  |  PubMed  |  Direct Link  |  

  4. Khasawneh, F.T., J. Huang, F. Mir, S. Srinivasan, C. Tiruppathi and G.C. Le Breton, 2008. Characterization of isoprostane signaling: Evidence for a unique coordination profile of 8-iso-PGF2α with the thromboxane A2 receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets. Biochem. Pharmacol., 75: 2301-2315.
    CrossRef  |  PubMed  |  Direct Link  |  

  5. Khasawneh, F.T., J. Huang, J. Turek and G.C. Le Breton, 2006. Differential mapping of the amino acids mediating agonist and antagonist coordination with the human thromboxane A2 receptor protein. J. Biol. Chem., 281: 26951-26965.
    CrossRef  |  PubMed  |  Direct Link  |